EUR 0.45
(-2.68%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.40 GBP | -29.03% |
2022 | -0.31 GBP | -121.43% |
2021 | -0.14 GBP | -107.22% |
2020 | 1.94 GBP | 2761.18% |
2019 | -0.07 EUR | 33.73% |
2018 | -0.11 EUR | 47.62% |
2017 | -0.21 EUR | 47.5% |
2016 | -0.40 EUR | 73.51% |
2015 | -1.51 EUR | -132.31% |
2014 | -0.65 EUR | -132.14% |
2013 | -0.28 EUR | -64.71% |
2012 | -0.17 EUR | 19.05% |
2011 | -0.21 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 FY | - GBP | -29.03% |
2023 Q1 | -0.07 GBP | 51.29% |
2023 Q2 | -0.07 GBP | -2.35% |
2023 Q4 | -0.33 EUR | 0.0% |
2022 Q4 | -0.14 GBP | 0.0% |
2022 FY | - GBP | -121.43% |
2022 Q2 | -0.15 GBP | 0.0% |
2022 Q3 | -0.14 GBP | 6.67% |
2021 Q2 | -0.21 EUR | 0.0% |
2021 FY | - GBP | -107.22% |
2021 Q4 | 0.05 EUR | 0.0% |
2020 FY | - GBP | 2761.18% |
2020 Q2 | 0.61 EUR | 0.0% |
2019 FY | - EUR | 33.73% |
2019 Q2 | -0.05 EUR | 0.0% |
2019 Q4 | -0.09 EUR | 0.0% |
2018 FY | - EUR | 47.62% |
2018 Q4 | -0.08 EUR | 0.0% |
2018 Q2 | - EUR | 0.0% |
2017 Q4 | - EUR | 0.0% |
2017 FY | - EUR | 47.5% |
2016 Q4 | - EUR | 0.0% |
2016 FY | - EUR | 73.51% |
2015 Q2 | - EUR | 0.0% |
2015 FY | - EUR | -132.31% |
2014 FY | - EUR | -132.14% |
2014 Q2 | - EUR | 0.0% |
2013 FY | - EUR | -64.71% |
2012 FY | - EUR | 19.05% |
2011 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Affluent Medical SA | -0.54 EUR | 25.926% |
Bluelinea Société Anonyme | -0.00 EUR | -399900.0% |
Carmat SA | -2.36 EUR | 83.051% |
Diagnostic Medical Systems S.A. | -0.56 EUR | 28.571% |
Euromedis Groupe | 4.60 EUR | 108.696% |
Eurobio Scientific Société anonyme | 0.43 EUR | 193.023% |
Ikonisys S.A. | -0.22 EUR | -81.818% |
Implanet S.A. | -0.17 EUR | -135.294% |
Median Technologies SA | -1.25 EUR | 68.0% |
SpineGuard SA | -0.11 EUR | -263.636% |
Theraclion SA | -0.08 EUR | -397.512% |
Euroapi S.A. | -2.01 EUR | 80.1% |
Guerbet SA | 1.90 EUR | 121.053% |